Drug research

AT-1501

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Tegoprubart

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)NCT05125068	Eledon Pharmaceuticals	Phase 2	Terminated	2023-07-31Actual
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380	Eledon Pharmaceuticals	Phase 2	Enrolling by invitation	2029-12Estimated
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770	Eledon Pharmaceuticals	Phase 2	Completed	2025-09-11Actual

Eledon PharmaceuticalsTerminatedPrimary completion: 2023-07-31 · Actual

Trial details

Eledon PharmaceuticalsEnrolling by invitationPrimary completion: 2029-12 · Estimated

Trial details

Eledon PharmaceuticalsCompletedPrimary completion: 2025-09-11 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.